🇺🇸 FDA
Patent

US 11351124

Sustained release of formulations of local anesthetics

granted A61KA61K31/445A61K9/0024

Quick answer

US patent 11351124 (Sustained release of formulations of local anesthetics) held by Eupraxia Pharmaceuticals Inc. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Eupraxia Pharmaceuticals Inc.
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/445, A61K9/0024, A61K9/0085, A61K9/5026